| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 Oxford University Press
CORRESPONDENCE |
Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Affiliations of authors: Colorectal Medicine and Genetics (FW), Familial Cancer Clinic (MH), The Royal Melbourne Hospital, 3050, Victoria, Australia
Correspondence to: Finlay Macrae, MBBS (Hons1), MD, FRACP, FRCP, Head, Colorectal Medicine and Genetics, PO Box 2010, The Royal Melbourne Hospital, 3050, Victoria, Australia (e-mail: finlay.macrae@mh.org.au).
| The first 10% of the full text of this article appears below. |
The revised Bethesda Guidelines were long awaited by practitioners in the field. The commentary on the new guidelines (1), however, raises concerns. Two versions of the revised Bethesda Guidelines that were determined at the 2002 National Cancer Institute hereditary nonpolyposis colorectal cancer (HNPCC) workshop were published in February 2004. One version was published in the Journal (1
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 937-938.